The FDA Announces Two More Antacid Recalls Due to Cancer Risk

Two more companies recalled their ranitidine drugs, generic forms of Zantac, over concerns they may contain a carcinogenic substance.

source https://www.wired.com/story/the-fda-announces-two-more-antacid-recalls-due-to-cancer-risk